Bruker Launches D8 VENTURE BIOTOOLS For Home Laboratory
Zacks Investment Research | Aug 21, 2017 09:57PM ET
Headquartered in Billerica, MA, Bruker Corporation (NASDAQ:BRKR) is focusing on strengthening its position in the growing scientific instruments market. In line with this, the company recently announced D8 VENTURE BIOTOOLS for laboratory macromolecular crystallography. This will be part of the Bruker AXS segment within Bruker Nano.
The D8 VENTURE BIOTOOLS has a few latest features in terms of source, detector and sample handling technology. As per the company, it features the new ImS DIAMOND (IµS DIAMOND), the brightest microfocus X-ray source. Also, IµS DIAMOND can run continuously without any routine maintenance. Bruker also offers 99% uptime guarantee with this new technology.
Further, the latest version of Excillum METALJET is a powerful alternative to the compact, microfocus IµS DIAMOND.
According to Bruker, D8 VENTURE BIOTOOLS features the new PHOTON III, the largest photon-counting pixel array detector for the home laboratory.
As per the company, the new SCOUT automated cryo-cooled crystal-handling system features a ceiling-mounted robot for sampling handling and state-of-the-art cryogenic technology. SCOUT incorporates the new AGH automated goniometer head. The AGH allows samples to be aligned automatically with X-rays.
Management believes that D8 VENTURE BIOTOOLS has enabled the company to set new standards in crystallography systems for the home laboratory. According to a report by Markets and Markets, the protein crystallization market is estimated to see a CAGR of 10.1% to reach a worldwide market of $1,253 million by 2018.
One of the recent developments in the Bruker Nano segment is the launch of the next-generation Wavelength Dispersive X-Ray Fluorescence (WDXRF) spectrometer, S8 TIGER Series 2. This is a versatile WDXRF tool available for advanced quantitative elemental analysis in industrial and academic materials research along with industrial quality control (QC) of materials.
In the last three reported quarters, the Bruker Nano business saw profits from the prior restructuring and cost actions. In the last reported second quarter, solid growth was driven by contributions from Hysitron nanoindenting product's acquisition in late January and improved results at the AXS business.
Bruker has been trading above the broaderZacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.